Functional imaging of immune cell subpopulations in the tumor microenvironment: clinical implications

Research output: Contribution to journalEditorialpeer-review

2 Scopus citations
Original languageEnglish (US)
Article numbere162962
JournalJournal of Clinical Investigation
Volume132
Issue number16
DOIs
StatePublished - Aug 15 2022

Funding

Support was provided by the Northwestern Medicine Malnati Brain Tumor Institute of the Lurie Cancer Center and NIH grants NS120547 and CA120813. Conflict of interest: ABH serves on the advisory board of Caris Life Sciences and the WCG Oncology Advisory Board; receives royalty and milestone payments from DNAtrix for the licensing of “Biomarkers and combination therapies using oncolytic virus and immunomodulation” (patent 11,065,285); and is supported by research grants from Celu-larity, Codiak BioSciences, and AbbVie. She additionally has active granted patents for “miRNA for treating cancer and for use with adoptive immunotherapies” (patent 9,675,633) and “Concurrent chemotherapy and immunotherapy” (patent 9,399,662), with a patent pending for “Low intensity ultrasound combination cancer therapies” (International applications PCT/US2022/019435 and US 63/158,642). Copyright: © 2022, Heimberger et al. This is an open access article published under the terms of the Creative Commons Attribution 4.0 International License. Reference information: J Clin Invest. 2022;132(16):e162962. https://doi.org/10.1172/JCI162962.

ASJC Scopus subject areas

  • General Medicine

Cite this